health
RevMed’s pancreatic cancer pill priced above $475,000 a year
Revolution Medicines Inc. won U.S. approval for a breakthrough pill that lengthens the lives of patients with advanced pancreatic cancer, a major advance against one of the hardest-to-treat tumor types.
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories
Moody? Aggressive? You could have ‘irritable male syndrome’
New York Post
Ozempic and Wegovy linked to brain health risks from caloric cuts
Fox News
After 20 Miscarriages, Mom Celebrates Son’s First Birthday: ‘I Couldn’t Give Up’ (Exclusive)
Yahoo
5 Georgia siblings diagnosed with measles
WSB-TV
People Who Drink Their Own Pee Are Obsessed With AI, Using It to Reassure Themselves That It's a Miraculous Cure-All
Futurism